Main content

Scientifica 2015

“Wenn Licht krank macht”

Scientifica – Zürcher Wissenschaftstage 2015

On September 4-6th we presented our project on erythropoietic protoporphyria to members of the Swiss public at the annual Scientifica event. The contributors to the event were: Profs. Elisabeth Minder and Xiaoye Schneider-Yin and Dr. Jasmin Barman-Aksözen from the Institute for Laboratory Medicine, Stadtspital Triemli, Zurich; Prof. Jonathan Hall from the Institute for Pharmaceutical Sciences, ETH Zurich; and Prof. Daniel Schümperli from the Institute for Cell Biology, University Bern.

The project is funded by the National Center of Competence in Research (NCCR) RNA & Disease.

To learn more go to: www.nccr-rna-and-disease.ch

Drug Discovery Network ZH

A major goal of the Drug Discovery Network Zurich (DDNZ) is to bring together Zurich-based researchers from backgrounds spanning basic research to clinical research in order to help them advance their research towards translational applications. This may comprise, but is not limited to, developing new methods for drug discovery, testing new compounds in translational medicine and sharing technical expertise or capacity.

“The DDNZ will hold another one-day symposium in the ETH Main Building of posters, short talks and plenary lectures on February 10th 2017 on “Drug Re-purposing in the Academic Environment”. Drug re-purposing offers opportunities and challenges to academics in many areas from chemistry through biology, pharmacology and translational research. We believe that this is an excellent theme to bring members of the DDNZ together.

To learn more go to: http://www.hochschulmedizin.uzh.ch/

A Swiss research focus on RNA

As part of the network, we operate an RNA synthesis platform to help collaborators access complex RNA structures.

Our Group is part of the newly started national NCCR initiative “RNA and Disease” (please click here (PDF, 586 KB)). We are collaborating with groups in Basel and Bern on projects related to:

  • The role of Muscleblind (MBNL1) in miRNA biogenesis and its effects on myotonic dystrophy and cardiac dysfunction
  • Splicing correction of the ferrochelatase gene for treatment of erythropoietic protoporphyria (EPP)
  • Non-canonical mechanisms of miRNA – mRNA regulation.

 

 
 
Page URL: http://www.pharmaceutical-chemistry.ethz.ch/
Sun Feb 26 22:00:18 CET 2017
© 2017 Eidgenössische Technische Hochschule Zürich